154 related articles for article (PubMed ID: 35801771)
21. [Alveolar soft part sarcoma: a clinicopathologic analysis of 48 cases].
Cheng J; Tu P; Wang J; He Y; Yu B; Rao Q; Zhou X; Shi Q
Zhonghua Bing Li Xue Za Zhi; 2016 Jan; 45(1):16-20. PubMed ID: 26791548
[TBL] [Abstract][Full Text] [Related]
22. An unusual case of primary splenic soft part alveolar sarcoma: case report and review of the literature with emphasis on the spectrum of TFE3-associated neoplasms.
Guérin R; Menard AL; Angot E; Piton N; Vera P; Schwarz L; Sabourin JC; Laé M; Thiébaut PA
Diagn Pathol; 2024 Apr; 19(1):62. PubMed ID: 38643139
[TBL] [Abstract][Full Text] [Related]
23. TFE3 immunoreactivity in alveolar soft part sarcoma of the uterine cervix: case report.
Roma AA; Yang B; Senior ME; Goldblum JR
Int J Gynecol Pathol; 2005 Apr; 24(2):131-5. PubMed ID: 15782069
[TBL] [Abstract][Full Text] [Related]
24. Brain metastasis of crystal-deficient, CD68-positive alveolar soft part sarcoma: ultrastructural features and differential diagnosis.
Cykowski MD; Hicks J; Sandberg DI; Olar A; Bridge JA; Greipp PT; Navarro P; Kolodziej S; Bhattacharjee MB
Ultrastruct Pathol; 2015 Feb; 39(1):69-77. PubMed ID: 25268941
[TBL] [Abstract][Full Text] [Related]
25. ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma.
Tanaka M; Chuaychob S; Homme M; Yamazaki Y; Lyu R; Yamashita K; Ae K; Matsumoto S; Kumegawa K; Maruyama R; Qu W; Miyagi Y; Yokokawa R; Nakamura T
Nat Commun; 2023 Apr; 14(1):1957. PubMed ID: 37029109
[TBL] [Abstract][Full Text] [Related]
26. [Alveolar soft part sarcoma in children: a clinicopathological study of 13 cases].
Wang LY; Jia C; Zhang M; An HB; Zhang N; Wang L; Fu LB; He LJ
Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):134-138. PubMed ID: 32074725
[No Abstract] [Full Text] [Related]
27. Technique for differentiating alveolar soft part sarcoma from other tumors in paraffin-embedded tissue: comparison of immunohistochemistry for TFE3 and CD147 and of reverse transcription polymerase chain reaction for ASPSCR1-TFE3 fusion transcript.
Tsuji K; Ishikawa Y; Imamura T
Hum Pathol; 2012 Mar; 43(3):356-63. PubMed ID: 21835426
[TBL] [Abstract][Full Text] [Related]
28. Alveolar soft part sarcoma: a clinicopathological and immunohistochemical analysis of 26 cases emphasizing risk factors and prognosis.
Zhang Y; Huang Y; Qin Y; Yang N; Yang P; Li N; Feng Z
Diagn Pathol; 2024 Jan; 19(1):23. PubMed ID: 38291475
[TBL] [Abstract][Full Text] [Related]
29. Crystal-deficient alveolar soft-part sarcoma with cutaneous involvement: a case report.
Kacerovska D; Michal M; Nemcova J; Vanecek T; Kreuzberg B; Mrazkova P; Koudela K; Kazakov DV
Am J Dermatopathol; 2009 May; 31(3):272-7. PubMed ID: 19384069
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS).
Taylor AS; Mannan R; Pantanowitz L; Chinnaiyan AM; Dhanasekaran SM; Hrycaj S; Cao X; Chan MP; Lucas D; Wang XM; Mehra R
Med Oncol; 2024 Feb; 41(3):76. PubMed ID: 38393424
[TBL] [Abstract][Full Text] [Related]
31. Lingual Alveolar Soft Part Sarcoma in a 78-Year-Old Woman: A Case Report and Comprehensive Review of the Literature from 1952 to 2022.
Aksionau A; Dela Cruz NE; Meram AT; Cuellar-Saenz H; Aveni JR; Takei H
Head Neck Pathol; 2023 Mar; 17(1):265-274. PubMed ID: 36303014
[TBL] [Abstract][Full Text] [Related]
32. Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article.
Chen X; Yang Y; Gan W; Xu L; Ye Q; Guo H
Medicine (Baltimore); 2015 May; 94(19):e873. PubMed ID: 25984679
[TBL] [Abstract][Full Text] [Related]
33. Revisiting cytomorphology, including unusual features and clinical scenarios of 8 cases of alveolar soft part sarcoma with TFE3 immunohistochemical staining in 7 cases.
Rekhi B; Rao V; Ramadwar M
Cytopathology; 2021 Jan; 32(1):20-28. PubMed ID: 32853443
[TBL] [Abstract][Full Text] [Related]
34. Lingual alveolar soft part sarcoma with absent TFE3 rearrangement.
Alshahrani S; Khan A
Cancer Rep (Hoboken); 2021 Feb; 4(1):e1298. PubMed ID: 33026169
[TBL] [Abstract][Full Text] [Related]
35. Meningeal alveolar soft part sarcoma confirmed by characteristic ASPCR1-TFE3 fusion.
Bodi I; Gonzalez D; Epaliyange P; Gullan R; Fisher C
Neuropathology; 2009 Aug; 29(4):460-5. PubMed ID: 18713311
[TBL] [Abstract][Full Text] [Related]
36. Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma.
Hoshino M; Ogose A; Kawashima H; Izumi T; Hotta T; Hatano H; Morita T; Otsuka H; Umezu H; Yanoma S; Tsukuda M; Endo N
Cancer Genet Cytogenet; 2009 Apr; 190(2):75-80. PubMed ID: 19380023
[TBL] [Abstract][Full Text] [Related]
37. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma.
Lazar AJ; Das P; Tuvin D; Korchin B; Zhu Q; Jin Z; Warneke CL; Zhang PS; Hernandez V; Lopez-Terrada D; Pisters PW; Pollock RE; Lev D
Clin Cancer Res; 2007 Dec; 13(24):7314-21. PubMed ID: 18094412
[TBL] [Abstract][Full Text] [Related]
38. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.
Argani P; Lal P; Hutchinson B; Lui MY; Reuter VE; Ladanyi M
Am J Surg Pathol; 2003 Jun; 27(6):750-61. PubMed ID: 12766578
[TBL] [Abstract][Full Text] [Related]
39. Oral alveolar soft part sarcoma in childhood and adolescence: report of two cases and review of literature.
Argyris PP; Reed RC; Manivel JC; Lopez-Terrada D; Jakacky J; Cayci Z; Tosios KI; Pambuccian SE; Thompson LD; Koutlas IG
Head Neck Pathol; 2013 Mar; 7(1):40-9. PubMed ID: 22961078
[TBL] [Abstract][Full Text] [Related]
40. Bioinformatic analysis of patient-derived ASPS gene expressions and ASPL-TFE3 fusion transcript levels identify potential therapeutic targets.
Covell DG; Wallqvist A; Kenney S; Vistica DT
PLoS One; 2012; 7(11):e48023. PubMed ID: 23226201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
